½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1534238

¼¼°èÀÇ ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ½ÃÀå ±Ô¸ð Á¶»ç : À¯Çüº°, ¼ººÐº°, Á¦Çüº°, À¯Åë ä³Îº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)

Global Cardiovascular Health Supplements Market Size study, by Type, by Ingredients, by Dosage Form, by Distribution Channel and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 285 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀåÀº 2023³â ¾à 111¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2024³âºÎÅÍ 2032³â±îÁö 6% ÀÌ»óÀÇ °ßÁ¶ÇÑ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÉÇ÷°ü °Ç°­º¸Á¶Á¦´Â ÄÝ·¹½ºÅ×·ÑÀ» ³·Ãß°í Ç÷¾ÐÀ» °³¼±ÇÏ¿© °³ÀÎÀÇ ½ÉÀå °Ç°­À» À¯ÁöÇÏ´Â µ¥ µµ¿òÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¸ÃæÁ¦¿¡´Â ¾îÀ¯, ¿À¸Þ°¡ 3 Áö¹æ»ê, È«±¹ µî ½ÉÀå¿¡ ÁÁÀº »ýÈ°½À°ü¿¡ ÇʼöÀûÀÎ ¿µ¾ç¼Ò¸¦ ÇÔÀ¯ÇÑ °Ç°­±â´É½ÄÇ°ÀÌ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ ½ÄÀ̼¶À¯, ½ºÅ×·Ñ, ÄÚ¿£ÀÚÀÓQ10(CoQ10), ¾Æ¸¶¾¾À¯¿Í °°Àº õ¿¬ Çãºê ¼ººÐÀ¸·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù.

°Ç°­ÇÏÁö ¸øÇÑ »ýÈ°½À°üÀ¸·Î ÀÎÇÑ ½ÉÀå °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ½ÃÀåÀÇ ¼ºÀå¿¡ Å©°Ô ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÉÀå °Ç°­À» °³¼±ÇÏ°í ½ÉÀå Áúȯ°ú °ü·ÃµÈ Ãß°¡ ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇØ °íÇ°ÁúÀÇ ÀüÅëÀûÀÎ º¸ÃæÁ¦¸¦ äÅÃÇÏ´Â °í·ÉÈ­ Àα¸ÀÇ Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» °­È­ÇÏ°í ÀÖ½À´Ï´Ù. ¹Ì±¹ °¡Á¤ÀÇÇÐȸ¿¡¼­ 2022³â 9¿ù¿¡ ¹ßÇ¥ÇÑ ±â»ç¿¡ µû¸£¸é, ¸Å³â 60¸¸ 5,000¸íÀÇ ¹Ì±¹ÀÎÀÌ Ã³À½À¸·Î ½ÉÀ帶ºñ¸¦ °æÇèÇÏ°í ¾à 61¸¸ ¸íÀÌ Ã³À½À¸·Î ³úÁ¹ÁßÀ» °æÇèÇÑ´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ, Áõ°¡ÇÏ´Â ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§ÇØ ½ÅÁ¦Ç° Ãâ½Ã¿¡ ÁÖ·ÂÇÏ´Â ½ÃÀå ±â¾÷ÀÇ Áõ°¡´Â ½ÉÀå °Ç°­º¸Á¶Á¦ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­ÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹ÙÀÌ¿À ±â¹Ý Çöó½ºÆ½À¸·ÎÀÇ Àüȯ, Áö¼Ó°¡´ÉÇÑ Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼±È£µµ Áõ°¡, »ê¾÷ °£ ½ÃÀå È®´ë´Â ÇâÈÄ ¸î ³â µ¿¾È ´Ù¾çÇÑ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ºñ¿ë °æÀï·Â, ±ÔÁ¦ ±âÁØ Áؼö, Á¦ÇÑµÈ ÀçÈ°¿ë ´É·ÂÀº 2024-2032³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀå¿¡ µµÀüÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä« ¹× ±âŸ Áö¿ªÀÔ´Ï´Ù. ºÏ¹Ì´Â ¸ÅÃâ ±âÁØÀ¸·Î ¼¼°è ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ½ÃÀåÀ» ÁÖµµÇÏ°í ÀÖ´Â Áö¿ªÀÔ´Ï´Ù. ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀå¿¡´Â ½ÉÇ÷°üÁúȯ¿¡ ´ëÇÑ ÀÏ¹Ý ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁø °ÍÀÌ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹ ³» °Ç°­±â´É½ÄÇ° Á¦Á¶¾÷üµéÀÌ Ãµ¿¬ ÃßÃâ¹° Á¦Á¶¾÷ü¿ÍÀÇ Á¦ÈÞ¸¦ ÅëÇØ Çõ½ÅÀûÀÎ Á¦Ç°À» °³¹ß ¹× Ãâ½ÃÇÏ´Â µ¥ ÁÖ·ÂÇÏ°í ÀÖ´Â °Íµµ ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀå¿¡ ´õ¿í ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº ¾Æ½Ã¾Æ Àα¸ÀÇ ¶óÀÌÇÁ½ºÅ¸ÀÏ º¯È­·Î ÀÎÇÑ °íÄÝ·¹½ºÅ×·ÑÇ÷Áõ ¹× ÇãÇ÷¼º ½ÉÀåÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ÀÌ Áö¿ªÀÇ ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ äÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¿¹¹æ¾àÀ» º¹¿ëÇÏ´Â ÀüÅëÀû ½À°üÀ» µû¸£´Â »ç¶÷µéÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ Áö¿ª¿¡¼­ ÀÌ·¯ÇÑ º¸ÃæÁ¦ÀÇ ¼Òºñ°¡ ´õ¿í Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå ÁÖ¿ä ¿ä¾à

  • ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2032³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
  • ÁÖ¿ä µ¿Çâ
  • ºÒȲÀÇ ¿µÇâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦2Àå ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå Á¤ÀÇ¿Í Á¶»ç °¡Á¤

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ
  • Á¶»ç °¡Á¤
    • Æ÷ÇÔ°ú Á¦¿Ü
    • Á¦ÇÑ»çÇ×
    • °ø±ÞÃø ºÐ¼®
      • ÀÔ¼ö °¡´É¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ȯ°æ
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚÀÇ °üÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ±â¼úÀÇ Áøº¸
      • ģȯ°æ
      • ¼ÒºñÀÚ Àǽİú ¼ö¿ë
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÉÀåÁúȯ À¯º´·ü »ó½Â
    • õ¿¬ ¼ººÐÀ» Æ÷ÇÔÇÑ Á¦Ç°À¸·ÎÀÇ À̵¿ Áõ°¡
    • ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ Ãâ½Ã Áõ°¡
  • ½ÃÀå °úÁ¦
    • ºñ¿ë °æÀï
    • ±ÔÁ¦ ±âÁØ Áؼö
    • ÇÑÁ¤µÈ ÀçÈ°¿ë ´É·Â
  • ½ÃÀå ±âȸ
    • ¹ÙÀÌ¿À ±â¹Ý Çöó½ºÆ½À¸·ÎÀÇ À̵¿
    • Áö¼Ó°¡´ÉÇÑ Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚ ±âÈ£ »ó½Â
    • ¾÷°è¸¦ ÃÊ¿ùÇÑ ½ÃÀå È®´ë

Á¦4Àå ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è
    • Porter's Five Forces ¸ðµ¨·ÎÀÇ ¹Ì·¡ÁöÇâÀû Á¢±Ù¹ý
    • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • Æı«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦5Àå ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : À¯Çüº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå : ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • õ¿¬ º¸ÃæÁ¦
    • ÇÕ¼º º¸ÃæÁ¦

Á¦6Àå ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¼ººÐº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå : ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • ºñŸ¹Î°ú ¹Ì³×¶ö
    • Çãºê ÃßÃâ¹°
    • ±âŸ

Á¦7Àå ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Çüº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå : ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • Á¤Á¦
    • ĸ½¶
    • ±âŸ

Á¦8Àå ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : À¯Åë ä³Îº°, 2022-2032³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå : ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2032³â
    • º´¿ø ¾à±¹
    • µå·°½ºÅä¾î¿Í ¼Ò¸Å ¾à±¹
    • ¿Â¶óÀÎ ¾à±¹
    • ±âŸ

Á¦9Àå ½ÉÇ÷°ü °Ç°­º¸Á¶Á¦ ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2022-2032³â

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Amway(U.S.)
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ °¡¿ë¼º¿¡ µû¶ó ´Ù¸§)
      • Á¦Ç° °³¿ä
      • ½ÃÀå Àü·«
    • Thorne(U.S.)
    • Swisse Wellness Pty Ltd(Australia)
    • Herbalife International of America, Inc.(India)
    • BL Bio Lab, LLC.(U.S.)
    • Church & Dwight Co., Inc.(U.S.)
    • Vyta Health Limited.(Netherlands)
    • Gaia Herbs(U.S.)
    • Herb Pharm(U.S.)
    • Abbott Laboratories
    • Nature's Bounty Co.
    • GNC Holdings, LLC
    • Pfizer Inc.
    • Garden of Life, LLC
    • Himalaya Global Holdings Ltd.

Á¦11Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
ksm 24.09.11

Global Cardiovascular Health Supplements Market is valued at approximately USD 11.11 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6 % over the forecast period 2024-2032. Cardiovascular health supplements aid in the maintenance of an individual's heart health by lowering cholesterol and improving blood pressure, which if not addressed can cause the risk of heart disease. These supplements include dietary supplements containing essential nutrients, such as fish oil, omega-3 fatty acids, red yeast rice, and others for a heart-healthy lifestyle. It also consists of natural herbal ingredients, such as fiber, sterols, coenzyme Q10 (CoQ10), and flaxseed oil.

The rising prevalence of heart-related disorders due to unhealthy lifestyles is majorly contributing to the cardiovascular health supplements market growth. In addition, the increasing focus of the aging population on adopting high-quality conventional supplements for improving their heart health and preventing further complications related to heart diseases is also augmenting the market growth. According to an article published by the American Academy of Family Physicians in September 2022, every year, 605,000 Americans have their first heart attack and around 610,000 experience a stroke for the first time. Furthermore, an increasing number of market players, with a strong focus on the introduction of new products to meet the growing demand, are further accelerating the growth of the heart health supplements market. Moreover, the shift towards bio-based plastics, rising consumer preference for sustainable products and market expansion across industries present various lucrative opportunities over the forecast years. However, the cost competitiveness, compliance with regulatory standards and limited recycling capabilities are challenging the market growth throughout the forecast period of 2024-2032.

The key regions considered for the Global Cardiovascular Health Supplements Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is a dominating region in the Global Cardiovascular Health Supplements Market in terms of revenue. The market growth in the region is being attributed to factors including the increasing awareness of cardiovascular diseases among the general population. Moreover, the increasing focus of dietary supplement manufacturers on collaborations with natural extract manufacturers for the development and launch of innovative products in the U.S. is further anticipated to contribute to the market's growth in the region. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by the rising prevalence of hypercholesterolemia and ischemic heart disease due to changing lifestyles of the Asian population is contributing to the growing adoption of cardiovascular health supplements in the region. Moreover, the increasing number of people following their traditional practice of consuming preventive medicine will further augment the consumption of these supplements in the region.

Major market player included in this report are:

  • Amway (U.S.)
  • Thorne (U.S.)
  • Swisse Wellness Pty Ltd (Australia)
  • Herbalife International of America, Inc. (India)
  • BL Bio Lab, LLC. (U.S.)
  • Church & Dwight Co., Inc. (U.S.)
  • Vyta Health Limited. (Netherlands)
  • Gaia Herbs (U.S.)
  • Herb Pharm (U.S.)
  • Abbott Laboratories
  • Nature's Bounty Co.
  • GNC Holdings, LLC
  • Pfizer Inc.
  • Garden of Life, LLC
  • Himalaya Global Holdings Ltd.

The detailed segments and sub-segment of the market are explained below:

By Type:

  • Natural Supplements
  • Synthetic Supplements

By Ingredients:

  • Vitamins and Minerals
  • Herbal Extracts
  • Others

By Dosage Form:

  • Tablets
  • Capsules
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Cardiovascular Health Supplements Market Executive Summary

  • 1.1. Global Cardiovascular Health Supplements Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Type
    • 1.3.2. By Ingredients
    • 1.3.3. By Dosage Form
    • 1.3.4. By Distribution Channel
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Cardiovascular Health Supplements Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Cardiovascular Health Supplements Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rising Prevalence of Heart Diseases
    • 3.1.2. Increasing Shift Toward Products Containing Natural Ingredients
    • 3.1.3. Increased Launches of Cardiovascular Health Supplements
  • 3.2. Market Challenges
    • 3.2.1. Cost Competitiveness
    • 3.2.2. Compliance with Regulatory Standards
    • 3.2.3. Limited Recycling Capabilities
  • 3.3. Market Opportunities
    • 3.3.1. Shift towards Bio-based Plastics
    • 3.3.2. Rising Consumer Preference for Sustainable Products
    • 3.3.3. Market Expansion Across Industries

Chapter 4. Global Cardiovascular Health Supplements Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Cardiovascular Health Supplements Market Size & Forecasts by Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Cardiovascular Health Supplements Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Natural Supplements
    • 5.2.2. Synthetic Supplements

Chapter 6. Global Cardiovascular Health Supplements Market Size & Forecasts by Ingredients 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Cardiovascular Health Supplements Market: Ingredients Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Vitamins and Minerals
    • 6.2.2. Herbal Extracts
    • 6.2.3. Others

Chapter 7. Global Cardiovascular Health Supplements Market Size & Forecasts by Dosage Form 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Cardiovascular Health Supplements Market: Dosage Form Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Tablets
    • 7.2.2. Capsules
    • 7.2.3. Others

Chapter 8. Global Cardiovascular Health Supplements Market Size & Forecasts by Distribution Channel 2022-2032

  • 8.1. Segment Dashboard
  • 8.2. Global Cardiovascular Health Supplements Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 8.2.1. Hospital Pharmacies
    • 8.2.2. Drug Stores & Retail Pharmacies
    • 8.2.3. Online Pharmacies
    • 8.2.4. Others

Chapter 9. Global Cardiovascular Health Supplements Market Size & Forecasts by Region 2022-2032

  • 9.1. North America Cardiovascular Health Supplements Market
    • 9.1.1. U.S. Cardiovascular Health Supplements Market
      • 9.1.1.1. Type breakdown size & forecasts, 2022-2032
      • 9.1.1.2. Ingredients breakdown size & forecasts, 2022-2032
      • 9.1.1.3. Dosage Form breakdown size & forecasts, 2022-2032
      • 9.1.1.4. Distribution Channel breakdown size & forecasts, 2022-2032
    • 9.1.2. Canada Cardiovascular Health Supplements Market
  • 9.2. Europe Cardiovascular Health Supplements Market
    • 9.2.1. U.K. Cardiovascular Health Supplements Market
    • 9.2.2. Germany Cardiovascular Health Supplements Market
    • 9.2.3. France Cardiovascular Health Supplements Market
    • 9.2.4. Spain Cardiovascular Health Supplements Market
    • 9.2.5. Italy Cardiovascular Health Supplements Market
    • 9.2.6. Rest of Europe Cardiovascular Health Supplements Market
  • 9.3. Asia-Pacific Cardiovascular Health Supplements Market
    • 9.3.1. China Cardiovascular Health Supplements Market
    • 9.3.2. India Cardiovascular Health Supplements Market
    • 9.3.3. Japan Cardiovascular Health Supplements Market
    • 9.3.4. Australia Cardiovascular Health Supplements Market
    • 9.3.5. South Korea Cardiovascular Health Supplements Market
    • 9.3.6. Rest of Asia Pacific Cardiovascular Health Supplements Market
  • 9.4. Latin America Cardiovascular Health Supplements Market
    • 9.4.1. Brazil Cardiovascular Health Supplements Market
    • 9.4.2. Mexico Cardiovascular Health Supplements Market
    • 9.4.3. Rest of Latin America Cardiovascular Health Supplements Market
  • 9.5. Middle East & Africa Cardiovascular Health Supplements Market
    • 9.5.1. Saudi Arabia Cardiovascular Health Supplements Market
    • 9.5.2. South Africa Cardiovascular Health Supplements Market
    • 9.5.3. Rest of Middle East & Africa Cardiovascular Health Supplements Market

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Amway (U.S.)
      • 10.3.1.1. Key Information
      • 10.3.1.2. Overview
      • 10.3.1.3. Financial (Subject to Data Availability)
      • 10.3.1.4. Product Summary
      • 10.3.1.5. Market Strategies
    • 10.3.2. Thorne (U.S.)
    • 10.3.3. Swisse Wellness Pty Ltd (Australia)
    • 10.3.4. Herbalife International of America, Inc. (India)
    • 10.3.5. BL Bio Lab, LLC. (U.S.)
    • 10.3.6. Church & Dwight Co., Inc. (U.S.)
    • 10.3.7. Vyta Health Limited. (Netherlands)
    • 10.3.8. Gaia Herbs (U.S.)
    • 10.3.9. Herb Pharm (U.S.)
    • 10.3.10. Abbott Laboratories
    • 10.3.11. Nature's Bounty Co.
    • 10.3.12. GNC Holdings, LLC
    • 10.3.13. Pfizer Inc.
    • 10.3.14. Garden of Life, LLC
    • 10.3.15. Himalaya Global Holdings Ltd.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦